Hepatocyte growth factor attenuates collagen accumulation in a murine model of pulmonary fibrosis

被引:125
作者
Dohi, M
Hasegawa, T
Yamamoto, K
Marshall, BC
机构
[1] Univ Utah, Hlth Sci Ctr, Div Resp Crit Care & Occupat Pulm Med, Salt Lake City, UT 84132 USA
[2] Univ Tokyo, Grad Sch Med, Dept Allergy & Rheumatol, Tokyo, Japan
[3] Salt Lake VA Med Ctr, Salt Lake City, UT USA
关键词
D O I
10.1164/ajrccm.162.6.9908097
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
We investigated the in vivo effects of recombinant human hepatocyte growth factor (HGF) on epithelial cell proliferation in normal mouse lung and on the repair process that follows bleomycin-induced lung injury. Intratracheal administration of 100 mug of rhHGF to C57BL/6 mice led to proliferation of bronchial and alveolar epithelial cells as indicated by an increased number of cells staining for proliferating cell nuclear antigen (PCNA). The effect of HGF on the lung repair process was examined by administration of 100 mug of rhHGF on Day 3 and Day 6 after intratracheal injection of bleomycin to mice. We found that HGF significantly attenuated collagen accumulation induced by bleomycin as determined by quantitation of hydroxyproline content and by scoring of the extent of fibrosis. To explore the potential mechanisms involved in the beneficial effects of HGF, we performed in vitro studies with A549 pulmonary epithelial cells and found that HGF enhanced cell surface plasmin generation, expression of u-PA activity, and cell migration. In summary, HGF has potent in vivo and in vitro effects an epithelial cells, which suggests it may have a role in the therapy of pulmonary fibrosis.
引用
收藏
页码:2302 / 2307
页数:6
相关论文
共 37 条
[1]  
ADAMSON IYR, 1988, AM J PATHOL, V130, P377
[2]   SIMPLE METHOD OF ESTIMATING SEVERITY OF PULMONARY FIBROSIS ON A NUMERICAL SCALE [J].
ASHCROFT, T ;
SIMPSON, JM ;
TIMBRELL, V .
JOURNAL OF CLINICAL PATHOLOGY, 1988, 41 (04) :467-470
[3]   DEPRESSED BRONCHOALVEOLAR UROKINASE ACTIVITY IN PATIENTS WITH ADULT RESPIRATORY-DISTRESS SYNDROME [J].
BERTOZZI, P ;
ASTEDT, B ;
ZENZIUS, L ;
LYNCH, K ;
LEMAIRE, F ;
ZAPOL, W ;
CHAPMAN, HA .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (13) :890-897
[4]   Biological effects of targeted inactivation of hepatocyte growth factor-like protein in mice [J].
Bezerra, JA ;
Carrick, TL ;
Degen, JL ;
Witte, D ;
Degen, SJF .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (05) :1175-1183
[5]   HEPATOCYTE GROWTH-FACTOR SCATTER FACTOR INDUCES A VARIETY OF TISSUE-SPECIFIC MORPHOGENIC PROGRAMS IN EPITHELIAL-CELLS [J].
BRINKMANN, V ;
FOROUTAN, H ;
SACHS, M ;
WEIDNER, KM ;
BIRCHMEIER, W .
JOURNAL OF CELL BIOLOGY, 1995, 131 (06) :1573-1586
[6]  
BRODY AR, 1989, AM J PATHOL, V134, P133
[7]   Anticytokine approaches in pulmonary fibrosis: Bringing factors into focus [J].
Coker, RK ;
Laurent, GJ .
THORAX, 1997, 52 (03) :294-296
[8]   PATHOBIOLOGY OF PULMONARY FIBROSIS [J].
CROUCH, E .
AMERICAN JOURNAL OF PHYSIOLOGY, 1990, 259 (04) :L159-L184
[9]   Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene [J].
Eitzman, DT ;
McCoy, RD ;
Zheng, XX ;
Fay, WP ;
Shen, TL ;
Ginsburg, D ;
Simon, RH .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (01) :232-237
[10]  
ESPOSITO AL, 1983, AM REV RESPIR DIS, V128, P662